Intermountain INSPIRE Registry
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02450006|
Recruitment Status : Recruiting
First Posted : May 21, 2015
Last Update Posted : August 10, 2022
|Condition or disease|
This is an observational, non-randomized, open, long-term project to collect a variety of biological samples, in addition to usual or specialized care clinical information and laboratory test results, from patients who present to Intermountain Healthcare-affiliated facilities, with symptoms of any healthcare-related conditions, as well as from a general population including disease-free subjects. The INSPIRE Registry will include all subjects enrolled in the HHD registry (IRB # 1007406, approval date 01- 16-2009) and the cathlab database registry (IRB # 1008366, approval date 10/04/2000), as of IRB approval date of this INSPIRE amended protocol.
Since this is a registry database project, there are no investigational treatments, drugs or procedures associated with participation. Information obtained from this registry project will not have direct or immediate benefit for any of the participants.
Biological samples and subject information will be obtained during diagnostic procedures and/or treatment that are generally part of usual or specialized care for the underlying healthcare-related condition. Sample testing and registry data utilization for various research projects can be initiated only after the appropriate approval is obtained from a registry oversight/management committee, and when appropriate, the Institutional Review Board.
After informed consent is obtained from the patient, the biological samples will be obtained in one of the following ways:
- During a procedure from access lines inserted for the procedure, or
- When other ordered lab work is done, or
- As a separate sample collection if no other lab work is planned. Biological sample collection from the general population may be a separate blood draw and/or sample collection. Participating patients may be asked to provide one or more collections of biological samples. Biological samples may be used in current and future research tests multiple times, or until the sample is consumed. In addition, participating subjects may be asked to complete the IRBreviewed questionnaires.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||50000 participants|
|Observational Model:||Ecologic or Community|
|Target Follow-Up Duration:||50 Years|
|Official Title:||INtermountain Healthcare Biological Samples Collection Project and Investigational REgistry for the On-going Study of Disease Origin, Progression and Treatment (Intermountain INSPIRE Registry)|
|Study Start Date :||April 2015|
|Estimated Primary Completion Date :||April 2050|
|Estimated Study Completion Date :||April 2050|
- All-cause mortality [ Time Frame: 10 years ]
Biospecimen Retention: Samples With DNA
Examples of the biological samples that may be collected are as follows (but not limited to):
- Bone Marrow
- Buccal smear (cheek)
- Cerebrospinal fluid
- Synovial fluid
- Tissue samples (e.g. muscle, skin, nails, tumor, etc)
- Seminal fluid
- Genetic material extracted from any biological sample
- Other biological samples as identified by the Principal Investigator or Co-Investigators and agreed by the patient.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02450006
|Contact: Joseph B Muhlestein, MDfirstname.lastname@example.org|
|Contact: Patti Spenceremail@example.com|